Monopril Plus (Fosinopril Sodium, Hydrochlorothiazide)

Fosinopril sodium / hydrochlorothiazide, the active ingredients in Monopril Plus, are an ACE inhibitor combined with a thiazide diuretic presented as a tablet for oral use. They are indicated for the management of hypertension in adult patients.

GNH USA supplies Monopril Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Monopril Plus, an ACE inhibitor combined with a thiazide diuretic, is used to treat conditions related to elevated blood pressure.

- Hypertension: lowers systolic and diastolic pressure in adults with primary hypertension. - Edema associated with hypertension: promotes fluid excretion to reduce swelling. - Hypertension in patients with type 2 diabetes: helps achieve target blood pressure while addressing sodium retention.

Common Side Effects: - Cough: dry, persistent throat irritation. - Dizziness or light‑headedness, especially after standing. - Headache: mild to moderate intensity. - Increased urination: due to diuretic effect. - Electrolyte disturbances: such as low potassium. - Fatigue: general feeling of tiredness.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or airway. - Severe hypotension: marked drop in blood pressure causing fainting. - Acute kidney injury: sudden decline in renal function. - Hyperkalemia: elevated potassium levels. - Pancreatitis: inflammation of the pancreas.

Before initiating therapy, clinicians should assess patient suitability and monitor relevant parameters. - Blood pressure monitoring: ensure adequate control without excessive drop. - Renal function assessment: check serum creatinine and eGFR regularly. - Electrolyte surveillance: watch for potassium and sodium abnormalities. - Pregnancy safety: avoid use in pregnancy (Category D) due to fetal risk. - Discontinuation caution: do not stop abruptly; taper under medical supervision. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Monopril Plus may interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Aliskiren: combined use can cause renal impairment and hyperkalemia. - Potassium‑sparing diuretics or supplements: increase risk of dangerous hyperkalemia. - NSAIDs: may blunt antihypertensive effect and worsen renal function. - Lithium: ACE inhibition can raise lithium levels, risking toxicity. - Dual ACE inhibitor/ARB therapy: excessive renin‑angiotensin blockade.

Moderate Interactions (Monitor Closely): - Loop diuretics: additive diuretic effect may cause volume depletion. - Other antihypertensives: may enhance blood pressure lowering, requiring dose adjustment. - Beta‑blockers: combined effect on heart rate and blood pressure. - Calcium channel blockers: possible additive hypotensive effect. - Antidiabetic agents: blood glucose may improve, necessitating dose review.